Vasoactive intestinal peptide encapsulated in liposomes: Effects on systemic arterial blood pressure
- 31 December 1994
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 54 (15), PL247-PL252
- https://doi.org/10.1016/0024-3205(94)00425-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mechanisms of reversionThe FASEB Journal, 1993
- Cigarette smoke extract potentiates bradykinin-induced increases in microvascular permeabilityJournal of Applied Physiology, 1993
- Liposomes in Drug DeliveryDrugs, 1993
- Interleukin-2 in liposomes: Increased intravenous potency and less pulmonary toxicity in the ratDrug Development Research, 1992
- Vasoactive intestinal polypeptide biologic role in health and diseaseTrends in Endocrinology & Metabolism, 1991
- Catalytic Hydrolysis of Vasoactive Intestinal Peptide by Human AutoantibodyScience, 1989
- Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interactionBiochemistry, 1988
- Cardiovascular effects of vasoactive intestinal peptide in healthy subjectsThe American Journal of Cardiology, 1987
- High affinity peptide histidine isoleucine-preferring receptors in rat liverLife Sciences, 1987
- Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptidePeptide Science, 1982